Letter to the Editor: Proton Pump Inhibitors and Biliary Tract Cancer Risk: Causality or Reverse Causality?
Hepatology
.
2021 Dec;74(6):3555-3556.
doi: 10.1002/hep.32090.
Epub 2021 Sep 16.
Authors
Ruijie Zeng
1
2
,
Weihong Sha
1
,
Felix W Leung
3
4
,
Hao Chen
1
Affiliations
1
Department of Gastroenterology and Hepatology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
2
Shantou University Medical College, Shantou, China.
3
David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA.
4
Sepulveda Ambulatory Care Center, Veterans Affairs Greater Los Angeles Healthcare System, North Hills, CA.
PMID:
34351010
DOI:
10.1002/hep.32090
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Biliary Tract Neoplasms*
Causality
Humans
Proton Pump Inhibitors* / adverse effects
Substances
Proton Pump Inhibitors